Mucopolysaccharidosis (MPS) Treatment Market Report

Global and Region Mucopolysaccharidosis (MPS) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：196
  • REPORT CODE：GMM942755
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Mucopolysaccharidosis (MPS) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Mucopolysaccharidosis (MPS) Treatmentmarket, defines the market attractiveness level of Mucopolysaccharidosis (MPS) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Mucopolysaccharidosis (MPS) Treatment industry, describes the types of Mucopolysaccharidosis (MPS) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mucopolysaccharidosis (MPS) Treatment market and the development prospects and opportunities of Mucopolysaccharidosis (MPS) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mucopolysaccharidosis (MPS) Treatment market in Chapter 13.

    By Player:

    • Esteve

    • Abeona Therapeutics Inc

    • Takeda Pharmaceutical Company Limited

    • RegenxBio Inc

    • Bioasis Technologies Inc

    • BioMarin Pharmaceuticals, Inc

    • GC Pharma

    • Eloxx Pharmaceuticals

    • Paradigm Biopharmaceuticals Ltd

    • Inventiva

    • Ultragenyx Pharmaceutical Inc

    • Sarepta Therapeutics

    • Sangamo Therapeutics, Inc

    • Immusoft Corporation

    • JCR Pharmaceuticals Co Ltd

    By Type:

    • Stem Cell Therapies

    • Enzyme Replacement Therapies

    By End-User:

    • Hospitals

    • Clinics

    • Homecare

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Mucopolysaccharidosis (MPS) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Mucopolysaccharidosis (MPS) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Mucopolysaccharidosis (MPS) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Mucopolysaccharidosis (MPS) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Mucopolysaccharidosis (MPS) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    • 7.2 United States Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    • 7.3 Europe Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    • 7.4 China Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    • 7.5 Japan Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    • 7.6 India Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    • 7.7 South Korea Mucopolysaccharidosis (MPS) Treatment Consumption (2017-2022)

    8 Region and Country-wise Mucopolysaccharidosis (MPS) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Mucopolysaccharidosis (MPS) Treatment Consumption Forecast (2022-2028)

    9 Global Mucopolysaccharidosis (MPS) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Stem Cell Therapies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Enzyme Replacement Therapies Consumption and Growth Rate (2017-2022)

    • 9.2 Global Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Homecare Consumption and Growth Rate (2017-2022)

    10 Global Mucopolysaccharidosis (MPS) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Stem Cell Therapies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Enzyme Replacement Therapies Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    11 Global Mucopolysaccharidosis (MPS) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Mucopolysaccharidosis (MPS) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Mucopolysaccharidosis (MPS) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Mucopolysaccharidosis (MPS) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Mucopolysaccharidosis (MPS) Treatment Market Competitive Analysis

    • 14.1 Esteve

      • 14.1.1 Esteve Company Details

      • 14.1.2 Esteve Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Esteve Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.2 Abeona Therapeutics Inc

      • 14.2.1 Abeona Therapeutics Inc Company Details

      • 14.2.2 Abeona Therapeutics Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abeona Therapeutics Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.3 Takeda Pharmaceutical Company Limited

      • 14.3.1 Takeda Pharmaceutical Company Limited Company Details

      • 14.3.2 Takeda Pharmaceutical Company Limited Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Takeda Pharmaceutical Company Limited Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.4 RegenxBio Inc

      • 14.4.1 RegenxBio Inc Company Details

      • 14.4.2 RegenxBio Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 RegenxBio Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.5 Bioasis Technologies Inc

      • 14.5.1 Bioasis Technologies Inc Company Details

      • 14.5.2 Bioasis Technologies Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bioasis Technologies Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.6 BioMarin Pharmaceuticals, Inc

      • 14.6.1 BioMarin Pharmaceuticals, Inc Company Details

      • 14.6.2 BioMarin Pharmaceuticals, Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 BioMarin Pharmaceuticals, Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.7 GC Pharma

      • 14.7.1 GC Pharma Company Details

      • 14.7.2 GC Pharma Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GC Pharma Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.8 Eloxx Pharmaceuticals

      • 14.8.1 Eloxx Pharmaceuticals Company Details

      • 14.8.2 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.9 Paradigm Biopharmaceuticals Ltd

      • 14.9.1 Paradigm Biopharmaceuticals Ltd Company Details

      • 14.9.2 Paradigm Biopharmaceuticals Ltd Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Paradigm Biopharmaceuticals Ltd Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.10 Inventiva

      • 14.10.1 Inventiva Company Details

      • 14.10.2 Inventiva Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.11 Ultragenyx Pharmaceutical Inc

      • 14.11.1 Ultragenyx Pharmaceutical Inc Company Details

      • 14.11.2 Ultragenyx Pharmaceutical Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ultragenyx Pharmaceutical Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.12 Sarepta Therapeutics

      • 14.12.1 Sarepta Therapeutics Company Details

      • 14.12.2 Sarepta Therapeutics Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Sarepta Therapeutics Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.13 Sangamo Therapeutics, Inc

      • 14.13.1 Sangamo Therapeutics, Inc Company Details

      • 14.13.2 Sangamo Therapeutics, Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Sangamo Therapeutics, Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.14 Immusoft Corporation

      • 14.14.1 Immusoft Corporation Company Details

      • 14.14.2 Immusoft Corporation Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Immusoft Corporation Mucopolysaccharidosis (MPS) Treatment Product and Service

    • 14.15 JCR Pharmaceuticals Co Ltd

      • 14.15.1 JCR Pharmaceuticals Co Ltd Company Details

      • 14.15.2 JCR Pharmaceuticals Co Ltd Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 JCR Pharmaceuticals Co Ltd Mucopolysaccharidosis (MPS) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Mucopolysaccharidosis (MPS) Treatment

    • Figure Mucopolysaccharidosis (MPS) Treatment Picture

    • Table Global Mucopolysaccharidosis (MPS) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mucopolysaccharidosis (MPS) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mucopolysaccharidosis (MPS) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Mucopolysaccharidosis (MPS) Treatment Consumption by Country (2017-2022)

    • Figure United States Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Mucopolysaccharidosis (MPS) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Mucopolysaccharidosis (MPS) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Mucopolysaccharidosis (MPS) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stem Cell Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Enzyme Replacement Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Stem Cell Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enzyme Replacement Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Mucopolysaccharidosis (MPS) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Mucopolysaccharidosis (MPS) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Esteve (Foundation Year, Company Profile and etc.)

    • Table Esteve Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Esteve Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Abeona Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Abeona Therapeutics Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abeona Therapeutics Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Limited Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Limited Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table RegenxBio Inc (Foundation Year, Company Profile and etc.)

    • Table RegenxBio Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table RegenxBio Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Bioasis Technologies Inc (Foundation Year, Company Profile and etc.)

    • Table Bioasis Technologies Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioasis Technologies Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table BioMarin Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table BioMarin Pharmaceuticals, Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMarin Pharmaceuticals, Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table GC Pharma (Foundation Year, Company Profile and etc.)

    • Table GC Pharma Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GC Pharma Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Eloxx Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Paradigm Biopharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Paradigm Biopharmaceuticals Ltd Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paradigm Biopharmaceuticals Ltd Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Inventiva (Foundation Year, Company Profile and etc.)

    • Table Inventiva Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inventiva Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Ultragenyx Pharmaceutical Inc (Foundation Year, Company Profile and etc.)

    • Table Ultragenyx Pharmaceutical Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ultragenyx Pharmaceutical Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Sarepta Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Sarepta Therapeutics Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sarepta Therapeutics Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Sangamo Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Sangamo Therapeutics, Inc Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Therapeutics, Inc Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table Immusoft Corporation (Foundation Year, Company Profile and etc.)

    • Table Immusoft Corporation Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immusoft Corporation Mucopolysaccharidosis (MPS) Treatment Product and Service

    • Table JCR Pharmaceuticals Co Ltd (Foundation Year, Company Profile and etc.)

    • Table JCR Pharmaceuticals Co Ltd Mucopolysaccharidosis (MPS) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table JCR Pharmaceuticals Co Ltd Mucopolysaccharidosis (MPS) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US